Multiple Sclerosis Clinical Trial

Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury

Summary

This study will examine the efficacy of a clinical intervention for improving emotional processing in individuals with MS and TBI.(1)The main outcome measure will be changes in emotional processing measures from pre to post treatment.

(2)This study will also assess the impact of the emotional processing intervention on changes in pre and post treatment depression and anxiety, as well as fatigue.(3) This study will additionally measure the impact of the emotional processing intervention on cognitive functioning, specifically processing speed, attention and executive abilities. This will be accomplished through the completion of a neuropsychological battery prior to and following the completion of treatment.(4)Finally, the investigators will measure the impact of the intervention on quality of life and social functioning, utilizing a pre and post treatment assessment consisting of measures of self-efficacy, quality of life, functional abilities, and awareness.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

diagnosis of Multiple Sclerosis or Traumatic Brain Injury
Fluent in English
processing speed impairment (based on evaluation)

Exclusion Criteria:

currently taking steroids and/or benzodiazepines
prior stroke or neurological diease
history of significant pyschiatric illness (for example, bipolar disorder, schizophrenia, or psychosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Epilepsy, Bipolar Disorder
significant alcohol or drug abuse history

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

29

Study ID:

NCT04408274

Recruitment Status:

Completed

Sponsor:

Kessler Foundation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Kessler Foundation
East Hanover New Jersey, 07936, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

29

Study ID:

NCT04408274

Recruitment Status:

Completed

Sponsor:


Kessler Foundation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider